Agios Pharmaceuticals stock fell >15% after the FDA extended the mitapivat sNDA PDUFA date for sickle cell disease to ...
Explore 6 supplements that may help manage sickle cell disease, their benefits, risks, and why consulting your healthcare ...
Egoavil and colleagues note that half of TAVI patients have anemia, in part because they tend to be older and frailer than ...
Gover's approach is to check both a complete blood count, or CBC, and ferritin at annual physicals for menstruating patients.
FDA recently requested additional information to evaluate whether a REMS is necessary for mitapivat in sickle cell diseaseFDA classified Agios’ response to the information request as a major amendment ...
A phase 3 clinical trial published in JAMA found trastuzumab rezetecan linked to 73% lower risk of cancer progression or ...
With the MF label expansion closed, Geron Corporation will focus on maximizing Rytelo's approved lower-risk MDS indication. I ...
Mayo Clinic researchers have found that genetic testing can help identify people who carry inherited blood disorder traits, ...
Financing co-led by Juvia Group and Lightspeed Venture Partners, with participation from an expanded syndicate of leading ...
Madhya Pradesh Chief Minister Dr. Mohan Yadav releases Modern Anemia Science: A Comprehensive Scientific Perspective, ...
Elizabeth Holmes vowed that a microsample of blood could unlock hundreds of diagnostic answers. How close can genuine ...
At current standard of care, less than half of women with recurrent platinum sensitive ovarian cancer who have had prior treatment with poly(ADP-ribose) polymerase inhibitors respond to subsequent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results